The metabolomics and lipidomics window into thyroid cancer research

References

• Abdel Rahman, A.M., et al., 2014. Targeted metabolomics in cultured cells and tissues by mass spectrometry: method development and validation. Analytica Chimica Acta, 845, 53–61.
   PubMed Web of Science ®Google Scholar
• Alonso,A., et al., 2015. Analytical methods in untargeted metabolomics: state of the art in 2015. frontiers in bioengineering and biotechnology, 3, 1–20.
   PubMedGoogle Scholar
• Astarita, G., Ahmed, F., and Piomelli, D., 2009. Lipidomic analysis of biological samples by liquid chromatography coupled to mass spectrometry. Lipidomics, Methods in Molecular Biology, 579, 201–218.
   PubMedGoogle Scholar
• Blasco, H., et al., 2015. Comparative analysis of targeted metabolomics: dominance-based rough set approach versus orthogonal partial least square-discriminant analysis. Journal of Biomedical Informatics, 53, 291–299.
   PubMed Web of Science ®Google Scholar
• Cai, Y., et al., 2015. An integrated targeted metabolomic platform for high-throughput metabolite profiling and automated data processing. Metabolomics, 11, 1575–1586.
   Web of Science ®Google Scholar
• Checa, A., Bedia, C., and Jaumot, J., 2015. Lipidomic data analysis: tutorial, practical guidelines and applications. Analytica Chimica Acta, 885, 1–16.
   PubMed Web of Science ®Google Scholar
• Chen, M., et al., 2015. GC–MS-based metabolomic analysis of human papillary thyroid carcinoma tissue. International Journal of Molecular Medicine, 36, 1607–1614.
   PubMed Web of Science ®Google Scholar
• Claudino, W.M., et al., 2012. Metabolomics in cancer: a bench-to-bedside intersection. Critical Reviews in Oncology/Hematology, 84, 1–7.
   PubMed Web of Science ®Google Scholar
• Damante, G., Scaloni, A., and Tell, G., 2009. thyroid tumors: novel insights from proteomic studies. Expert Rev Proteomics, 6, 363–376.
   PubMed Web of Science ®Google Scholar
• Deja, S., et al., 2013. Follicular adenomas exhibit a unique metabolic profile. 1H NMR studies of thyroid lesions. PLoS ONE, 8, e84637.
   PubMed Web of Science ®Google Scholar
• Di Gangi, I.M., et al., 2014. Analytical metabolomics-based approaches to pancreatic cancer. Trends in Analytical Chemistry, 55, 94–116.
   Web of Science ®Google Scholar
• Duarte, I.F., Diaz, S.O., and Gil, A.M., 2014. NMR metabolomics of human blood and urine in disease research. Journal of Pharmaceutical and Biomedical Analysis, 93, 17–26.
   PubMed Web of Science ®Google Scholar
• Duarte, I.F. and Gil, A.M., 2012. Metabolic signatures of cancer unveiled by NMR spectroscopy of human biofluids. Progress in Nuclear Magnetic Resonance Spectroscopy, 62, 51–74.
   PubMed Web of Science ®Google Scholar
• Dudley, E., et al., 2010. Targeted metabolomics and mass spectrometry. Advances in Protein Chemistry and Structural Biology, 80, 45–83.
   PubMed Web of Science ®Google Scholar
• Armitage, E.G. and Barbas, C., 2014. Metabolomics in cancer biomarker discovery: current trends and future perspectives. Journal of Pharmaceutical and Biomedical Analysis, 87, 1–11.
   PubMed Web of Science ®Google Scholar
• Erler, P., et al., 2014. Dicer expression and microRNA dysregulation associate with aggressive features in thyroid cancer. Surgery, 156, 1342–1350.
   PubMed Web of Science ®Google Scholar
• Fagin, J.A. and Mitsiades, N., 2008. Molecular pathology of thyroid cancer: diagnostic and clinical implications. Best Practice & Research Clinical Endocrinology & Metabolism, 22, 955–969.
   PubMed Web of Science ®Google Scholar
• Fathi, F., et al., 2013. NMR based metabonomics study on celiac disease in the blood serum. Gastroenterology and Hepatology from Bed to Bench, 6, 190–194.
   PubMedGoogle Scholar
• Fathi, F., et al., 2014a. A metabonomics study on celiac disease by CART. International Journal of Celiac Disease, 2, 44–46.
   Google Scholar
• Fathi, F., et al., 2014b. The differential diagnosis of Crohn’s disease and celiac disease using nuclear magnetic resonance spectroscopy. Applied Magnetic Resonance, 45, 451–459.
   Web of Science ®Google Scholar
• Ganti, S. and Weiss, R.H., 2011. Urine metabolomics for kidney cancer detection and biomarker discovery. Urologic Oncology: Seminars and Original Investigations, 29, 551–557.
   PubMed Web of Science ®Google Scholar
• Griffin, JL., et al., 2004. Metabolic profiles of cancer calls. Nat Rev Cancer, 4, 551–561.
   PubMed Web of Science ®Google Scholar
• Grivet, JP., et al., 2003. NMR and microbiology: from physiology to metabolomics. Biochimie, 85, 823–840.
   PubMed Web of Science ®Google Scholar
• Grogan, R.H., Mitmaker, E.J., and Clark, O.H., 2010. The evolution of biomarkers in thyroid cancer-from mass screening to a personalized biosignature. Cancers, 2, 885–912.
   PubMedGoogle Scholar
• Gromski, P.S., et al., 2015. A tutorial review: metabolomics and partial least squares-discriminant analysis-a marriage of convenience or a shotgun wedding. Analytica Chimica Acta, 879, 10–23.
   PubMed Web of Science ®Google Scholar
• Gu, Y., et al., 2015. Preoperative dynamics and significance of amino acid profiles in patients with cancer. Journal of Translational Medicine, 13, 14.
   PubMed Web of Science ®Google Scholar
• Guo, L., et al., 2015. Exhaled breath volatile biomarker analysis for thyroid cancer. Translational Research, 166, 188–195.
   PubMed Web of Science ®Google Scholar
• Guo, S., et al., 2014. Tissue imaging and serum lipidomic profiling for screening potential biomarkers of thyroid tumors by matrix-assisted laser desorption/ionization-Fourier transform ion cyclotron resonance mass spectrometry. Analytical and Bioanalytical Chemistry, 406, 4357–4370.
   PubMed Web of Science ®Google Scholar
• Gupta, N., et al., 2011. Evaluation of the role of magnetic resonance spectroscopy in the diagnosis of follicular malignancies of thyroid. Archives of Surgery, 146, 179–182.
   PubMed Web of Science ®Google Scholar
• Halama, A., 2014. Metabolomics in cell culture – a strategy to study crucial metabolic pathways in cancer development and the response to treatment. Archives of Biochemistry and Biophysics, 564, 100–109.
   PubMed Web of Science ®Google Scholar
• Hiller, K. and Metallo, C.M., 2013. Profiling metabolic networks to study cancer metabolism. Current Opinion in Biotechnology, 24, 60–68.
   PubMed Web of Science ®Google Scholar
• Ishikawa, S., et al., 2012. Increased expression of phosphatidylcholine (16:0/Q3 18:1) and (16:0/18:2) in thyroid papillary cancer. PLOS ONE, 7, e48873.
   PubMed Web of Science ®Google Scholar
• Jordan, K.W., et al., 2011. Application of magnetic-resonance-spectroscopy-based metabolomics to the fine-needle aspiration diagnosis of papillary thyroid carcinoma. Acta Cytologica, 55, 584–589.
   PubMed Web of Science ®Google Scholar
• Kaur, P., et al., 2012. Metabolomic profiling for biomarker discovery in pancreatic cancer. International Journal of Mass Spectrometry, 310, 44–51.
   Web of Science ®Google Scholar
• King, A.D., et al., 2005. In vivo 1H MR spectroscopy of thyroid carcinoma. European Journal of Radiology, 54, 112–117.
   PubMed Web of Science ®Google Scholar
• La, S., et al., 2003. Capillary electrophoretic profiling and pattern recognition analysis of urinary nucleosides from thyroid cancer patients. Analytica Chimica Acta, 486, 171–182.
   Web of Science ®Google Scholar
• Liao, Y., et al., 2003. Increase of AKT/PKB expression correlates with gleason pattern in human prostate cancer. International Journal of Cancer, 107, 676–680.
   PubMed Web of Science ®Google Scholar
• Ma, H. and Zhao, H., 2013. Drug target inference through pathway analysis of genomics data. Advanced Drug Delivery Reviews, 65, 966–972.
   PubMed Web of Science ®Google Scholar
• Mackinnon, W.B., et al., 1996. Two-dimensional proton magnetic resonance spectroscopy for tissue characterization of thyroid neoplasms. World Journal of Surgery, 20, 841–847.
   PubMed Web of Science ®Google Scholar
• Meleh, M., et al., 2007. Determination of serum lysophosphatidic acid as a potential biomarker for ovarian cancer. Journal of Chromatography B Analytical Technologies in the Biomedical and Life Sciences, 858, 287–291.
   PubMed Web of Science ®Google Scholar
• Miccoli, P., et al., 2012. Metabolomics approach to thyroid nodules: a high-resolution magic-angle spinning nuclear magnetic resonance-based study. Surgery, 152, 1118–1124.
   PubMed Web of Science ®Google Scholar
• Murph, M., et al., 2007. Liquid chromatography mass spectrometry for quantifying plasma lysophospholipids: potential biomarkers for cancer diagnosis. Methods in Enzymology, 433, 1–25.
   PubMed Web of Science ®Google Scholar
• Mussap, M., et al., 2013. The role of metabolomics in neonatal and pediatric laboratory medicine. Clinica Chimica Acta, 426, 127–138.
   PubMed Web of Science ®Google Scholar
• Navas-Carrillo, D., et al., 2014. Familial nonmedullary thyroid cancer: screening, clinical, molecular and genetic findings. Biochimica Et Biophysica Acta, 1846, 468–476.
   PubMed Web of Science ®Google Scholar
• Nobakht, B.F., et al., 2016. NMR- and GC/MS-based metabolomics of sulfur mustard exposed individuals: a pilot study. Biomarkers, 21, 1–11.
   PubMed Web of Science ®Google Scholar
• Nobakht, M.Gh.B.F., et al., 2015. The metabolomics of airway diseases, including COPD, asthma and cystic fibrosis. Biomarkers, 20, 5–16.
   PubMed Web of Science ®Google Scholar
• Omura, O. and Baran, Y., 2014. An update on molecular biology of thyroid cancers. Critical Reviews in Oncology/Hematology, 90, 233–252.
   PubMed Web of Science ®Google Scholar
• Patel, S. and Ahmed, S., 2015. Emerging field of metabolomics: big promise for cancer biomarker identification and drug discovery. Journal of Pharmaceutical and Biomedical Analysis, 107, 63–74.
   PubMed Web of Science ®Google Scholar
• Putri, S.P., et al., 2013. Current metabolomics: practical applications. Journal of Bioscience and Bioengineering, 115, 579–589.
   PubMed Web of Science ®Google Scholar
• Raffelt, K., et al., 2000. Systemic alterations in phospholipid concentrations of blood plasma in patients with thyroid carcinoma: an in-vitro 31P high-resolution NMR study. NMR in Biomedicine, 13, 8–13.
   PubMed Web of Science ®Google Scholar
• Ramautar, R., et al., 2013. CE-MS for metabolomics: Developments and applications in the period 2010–2012. Electrophoresis, 34, 86–98.
   PubMed Web of Science ®Google Scholar
• Ramautar, R., et al., 2015. CE-MS for metabolomics: Developments and applications in the period 2012–2014. Electrophoresis, 36, 212–224.
   PubMed Web of Science ®Google Scholar
• Rezaei-Tavirani, M., et al., 2012. Advantage of applying OSC to 1H NMR-based metabonomic data of celiac disease. International Journal of Endocrinology and Metabolism, 10, 548–552.
   PubMedGoogle Scholar
• Russell, P., et al., 1994. Proton magnetic resonance and human thyroid neoplasia I: discrimination between benign and malignant neoplasms. The American Journal of Medicine, 96, 383–388.
   PubMed Web of Science ®Google Scholar
• Saddoughi, S.A., Song, P., and Ogretmen, B., 2008. Roles of bioactive sphingolipids in cancer biology and therapeutics. Subcellular Biochemistry, 49, 413–440.
   PubMedGoogle Scholar
• Sarkar, S., et al., 2005. Sphingosine kinase 1 is required for migration, proliferation and survival of MCF7 human breast cancer cells. FEBS Letters, 579, 5313–5317.
   PubMed Web of Science ®Google Scholar
• Schauer, N., et al., 2005. GC-MS libraries for the rapid identification of metabolites in complex biological samples. FEBS lett, 579, 1332–1337.
   PubMed Web of Science ®Google Scholar
• Shang, X., Zhong, X., and Tian, X., 2016. Metabolomics of papillary thyroid carcinoma tissues: potential biomarkers for diagnosis and promising targets for therapy. Tumor Biology, 37, 11163–11175.
   PubMed Web of Science ®Google Scholar
• Shujahan-Haq, A.N., Cheema, M.S., and Clarke, R., 2015. Application of metabolomics in drug resistant breast cancer research. Metabolites, 5, 100–118.
   PubMed Web of Science ®Google Scholar
• Smedsgaard, J., et al., 2005. Metabolite profiling of fungi and yeast: from phenotype to metabolome by MS and informatics. J Exp Bot, 56, 273–286.
   PubMed Web of Science ®Google Scholar
• Song, H., et al., 2012. Serum metabolic profiling of human gastric cancer based on gas chromatography/mass spectrometry. Brazilian Journal of Medical and Biological Research, 45, 78–85.
   PubMed Web of Science ®Google Scholar
• Sookie, La., et al., 2003. Capillary electrophoretic profiling and pattern recognition analysis of urinary nucleosides from thyroid cancer patients. Analytica Chimica Acta, 486, 171–182.
   Web of Science ®Google Scholar
• Sosa, J.A., et al., 2013. Increases in thyroid nodule fine-needle aspirations, operations, and diagnoses of thyroid cancer in the United States. Surgery, 154, 1420–1427.
   PubMed Web of Science ®Google Scholar
• Sudarshan, S., et al., 2013. Metabolism of kidney cancer: from the lab to clinical practice. European Urology, 63, 244–251.
   PubMed Web of Science ®Google Scholar
• Suhre, K., 2014. Metabolic profiling in diabetes. Journal of Endocrinology, 221, 75–85.
   Web of Science ®Google Scholar
• Sutphen, R., et al., 2004. Lysophospholipids are potential biomarkers of ovarian cancer. Cancer Epidemiology, Biomarkers & Prevention, 13, 1185–1191.
   PubMed Web of Science ®Google Scholar
• Tenori, L., et al., 2012. Exploration of serum metabolomic profiles and outcomes in women with metastatic breast cancer: a pilot study. Molecular Oncology, 6, 437. e444.
   PubMed Web of Science ®Google Scholar
• Tian, Y., et al., 2015. Integrative metabonomics as potential method for diagnosis of thyroid malignancy. Scientific Reports, 5, 14869. 1–12.
   PubMed Web of Science ®Google Scholar
• Torregrossa, L., et al., 2012. Toward the reliable diagnosis of indeterminate thyroid lesions: a HRMAS NMR-based metabolomics case of study. Journal of Proteome Research, 11, 3317–3325.
   PubMed Web of Science ®Google Scholar
• Trock, B.J., 2011. Application of metabolomics to prostate cancer. Urologic Oncology: Seminars and Original Investigations, 29, 572–581.
   PubMed Web of Science ®Google Scholar
• Wang, M.T., Honn, K.V., and Nie, D., 2007. cyclooxygenases, prostanoids, and tumor progression. Cancer and Metastasis Reviews, 26, 525–534.
   PubMed Web of Science ®Google Scholar
• Wang, QZ., et al., 2006. Integrating metabolomics into a systems biology framework to exploit metabolic complexity: strategies and applications in microorganisms. Appl Microbiol Biotechnol, 70, 151–161.
   PubMed Web of Science ®Google Scholar
• Wojakowska, A., et al., 2015a. Detection of metabolites discriminating subtypes of thyroid cancer: molecular profiling of FFPE samples using the GC/MS approach. Molecular and Cellular Endocrinology, 417, 149–157.
   PubMed Web of Science ®Google Scholar
• Wojakowska, A., et al., 2015b. Application of metabolomics in thyroid cancer research. International Journal of Endocrinology, 2015, 1–13.
   Web of Science ®Google Scholar
• Wu, H., et al., 2010. metabolomic investigation of gastric cancer tissue using gas chromatography/mass spectrometry. Analytical and Bioanalytical Chemistry, 396, 1385–1395.
   PubMed Web of Science ®Google Scholar
• Yan, W., et al., 2009. PI3 kinase/AKT signaling mediates epithelial-mesenchymal transition in hypoxic hepatocellular carcinoma cells. Biochemical and Biophysical Research Communications, 382, 631–636.
   PubMed Web of Science ®Google Scholar
• Yao, Z., et al., 2011. Serum metabolic profiling and features of papillary thyroid carcinoma and nodular goiter. Molecular BioSystems, 7, 2608–2614.
   PubMed Web of Science ®Google Scholar
• Yoshioka, Y., et al., 2000. Quantitation by 1H-NMR of dolichol, cholesterol and choline-containing lipids in extracts of normal and pathological thyroid tissue. NMR in Biomedicine, 13, 377–383.
   PubMed Web of Science ®Google Scholar
• Zhang, A.H., et al., 2013. Metabolomics in noninvasive breast cancer. Clinica Chimica Acta, 424, 3–7.
   PubMed Web of Science ®Google Scholar
• Zhang,A., et al., 2012. Urine metabolomics. Clinica Chimica Acta, 414, 65–69.
   PubMed Web of Science ®Google Scholar